A new study led by Break Through Cancer's Accelerating Glioblastoma (GBM) Therapies Through Serial Biopsies TeamLab has revealed that an engineered virus therapy, CAN-3110, triggered powerful immune ...
The study involved two patients with recurrent GBM who underwent serial biopsies over four months of CAN-3110 treatment. Not only was the procedure well tolerated in these patients, but it also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback